Esophageal Cancer Clinical Trials in Osaka
2 recruitingOsaka, Japan
Showing 1–2 of 2 trials
Recruiting
Phase 3
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Esophageal CancerGastric CancerGastroesophageal Junction Adenocarcinoma
AstraZeneca2,130 enrolled230 locationsNCT07431281
Recruiting
Phase 1
AB122 Platform Study
Colorectal, CancerEsophageal CancerGastric Cancer+6 more
Taiho Pharmaceutical Co., Ltd.917 enrolled9 locationsNCT04999761